Patients with complex and chronic diseases, like psoriasis and psoriatic arthritis (together with the related systemic inflammation called psoriatic disease), often need high-cost specialty medications to manage their conditions and maintain their overall health and well-being. If psoriatic disease is left under-managed or untreated, it can lead to life-long physical and emotional impacts on those diagnosed, as well as significant economic burdens.
The extent of patient impact, the speed at which new developments occur in the treatment of psoriasis and psoriatic arthritis, and the cost of under-management necessitate that payers understand this disease.
This new program, hosted by the National Psoriasis Foundation, will provide the information you need to guide decision making around treatment and formularies. Our complementary discussion will offer relevant content on psoriatic disease including disease pathophysiology, diagnosis, treatment mechanism of action, comorbidities, and new and emerging therapies.
At a Glance
- 90-minute virtual program
- Complimentary registration
- Actionable information for health insurance payers
- Led by Kristina Callis Duffin, M.D., M.S. – a leading dermatologist and Vice Chair of the NPF Medical Board – with Leah Howard, J.D., Chief Operating Officer of the NPF and Stacie Bell, Ph.D., Chief Scientific and Medical Officer of the NPF
What You’ll Learn
- Understand psoriasis and differentiate it from other inflammatory skin conditions
- Understand psoriatic arthritis, including the early signs of joint involvement in psoriasis
- Conceptualize the role of insurers supporting improved health outcomes for individuals living with psoriatic disease
- Comprehend the burden of psoriatic disease beyond the skin, including associated comorbid conditions and psychosocial effects
- Appreciate guidelines for the management and treatment of psoriasis and psoriatic arthritis to better support treatment choices for this patient community